Evaluation of the Comparative Efficacy of an Ayurvedic Formulation (Nimba-Amalakyadi Powder) vs Metformin in the Management of Type 2 Diabetes Mellitus: Protocol for a Pilot Study - PubMed
5 hours ago
- #Ayurveda
- #Clinical Trial
- #Diabetes
- Study evaluates Ayurvedic formulation Nimba-Amalakyadi Powder vs Metformin for Type 2 Diabetes.
- Pilot study aims to assess feasibility, recruitment, retention, and adherence over 45 days.
- Primary outcomes include fasting blood sugar and HbA1c levels; secondary outcomes explore clinical trends.
- 36 participants divided into two groups: one on Metformin, the other on Nimba-Amalakyadi Powder.
- Follow-ups scheduled at 45 and 90 days to evaluate sustained effects.
- Preliminary results expected by January 2025, final results by June 2025.
- Study will compare efficacy and feasibility of Ayurvedic treatment versus conventional Metformin.